Evidence map›Paper›PMID 30072598›Full record

ReviewBiomedicines2018

Relapsing Polychondritis: An Updated Review.

Francesco Borgia, Roberta Giuffrida, Fabrizio Guarneri, Serafinella P Cannavò

Abstract readReview
In one paragraph

Review in Biomedicines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Article
  2. Calcified ears due to relapsing polychondritis.Wiener klinische Wochenschrift · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. A Case of Relapsing Polychondritis with Multisystemic Involvement.Clinical, cosmetic and investigational dermatology · 2025
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francesco BorgiaDepartment of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98125 Messina, Italy. fborgia@unime.it.
Roberta GiuffridaDepartment of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98125 Messina, Italy. robgiuffrida@unime.it.
Fabrizio GuarneriDepartment of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98125 Messina, Italy. f.guarneri@tiscali.it.
Serafinella P CannavòDepartment of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98125 Messina, Italy. cannavop@unime.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relapsing polychondritis is an immune-mediated systemic disease characterized by recurrent episodes of inflammation of cartilaginous and proteoglycan-rich tissues, resulting in progressive anatomical deformation and functional impairment of the involved structures. Auricular and nasal chondritis and/or polyarthritis represent the most common clinical features, but potentially all types of cartilage may be involved. Because of the pleomorphic nature of the disease, with non-specific symptoms at the onset, the diagnosis of relapsing polychondritis is often delayed. In this review article we provide a comprehensive look into clinical presentation, laboratory and instrumental investigations, diagnostic criteria, and therapeutic options.

Indexed as

anti-type II collagen antibodiesauricular chondritiscartilagerelapsing polychondritissystemic autoimmune disease

Identifiers

PMID30072598
PMCPMC6164217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.